Evidence map›Paper›PMID 40786233›Full record

ArticleScience and technology of advanced materials2025

Enhanced cancer immunotherapy via synergistic action of NO-Donor nanoparticles (Nano

Ting Mei, Xin Zhang, Xiaolu Hou, Yukio Nagasaki

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Science and technology of advanced materials, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ting MeiSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China.ORCID https://orcid.org/0009-0006-4326-4825
Xin ZhangSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China.
Xiaolu HouSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China.
Yukio NagasakiDepartment of Materials Science, Faculty of Pure and Applied Sciences, University of Tsukuba, Tsukuba Ibaraki, Japan.ORCID https://orcid.org/0000-0001-7975-6510

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study explores the synergistic potential of PEG-b-P(L-Arg)-based polyion complex micelles (Nano

Indexed as

cancer immunotherapyimmune checkpoint inhibitor (PD-1 antibody)nanoparticle-based nitric oxide donorpoly(L-arginine)-based polymer micellessynergistic anti-tumor effectTumor-associated macrophages

Identifiers

PMID40786233
PMCPMC12333000

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.